Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

PNE Aktie 2339409 / DE000A0JBPG2

11.11.2025 10:13:23

EQS-News: PNE wins bids in wind tender in France

EQS-News: PNE AG / Key word(s): Miscellaneous
PNE wins bids in wind tender in France

11.11.2025 / 10:13 CET/CEST
The issuer is solely responsible for the content of this announcement.


Corporate news

 PNE wins bids in wind tender in France

  • Two wind farms with a total capacity of 20.8 MW successfully approved
  • Modificative permits enable increased power generation

Cuxhaven, 11 November 2025 – The PNE Group was successful in the 10th tender for onshore wind energy in France. The “Romescamps” and “Chéry” wind farms were each winning bids.

The “Romescamps” wind farm, located in the Hauts-de-France region, has a total capacity of 10.8 MW. It will consist of three wind turbines. Commissioning is planned for the end of 2027. The “Chéry” wind farm in the Centre-Val de Loire region was also successful. In early 2029, two wind turbines with a total capacity of 10 MW are expected to be in operation here.

The PNE France team has succeeded, through a change permit, in adapting both projects to new rules and new turbines generation and taking advantage of some positive evolutions of initial constraints. This will significantly increase the expected power generation of both wind farms. Thanks to the competitive electricity price offered to this tender session, added value will be achieved.

‘We are delighted to have been successful in the tender,’ says Roland Stanze, COO of PNE AG. ‘This means we are continuing our success in the French market. It is particularly pleasing that, thanks to the efforts of the PNE France team, we were able to improve the economic efficiency of the wind farms while the development process was still ongoing. This means we are generating more clean energy and making an even greater contribution to climate protection.’

About the PNE Group

The internationally operating PNE Group is listed on the SDAX as well as the TecDAX. For more than 30 years, it has been one of the most experienced project developers in the area of onshore and offshore wind farms. The focus is on the development of wind energy and photovoltaic projects worldwide as well as on power generation with its own wind farms. Its portfolio covers all project planning phases, from site investigation, approval procedures and financing through to construction, operation and repowering. As a Clean Energy Solutions Provider, the PNE Group also offers services for the entire life cycle of wind farms and photovoltaic plants, as well as battery storage solutions for more efficient use of renewable energies. The PNE Group is a sought-after partner for industry when it comes to solutions for refining electricity using Power-to-X technologies.

Your contact persons:

PNE AG
Alexander Lennemann
Head of Corporate Communications
Tel: +49 47 21 7 18 – 453
E-mail: alexander.lennemann@pnegroup.com

PNE AG
Head of Investor Relations
Christopher Rodler
Tel: +49 40 879 33 – 114
E-mail: christopher.rodler@pnegroup.com


11.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: PNE AG
Peter-Henlein-Strasse 2-4
27472 Cuxhaven
Germany
Phone: 04721 / 718 - 06
Fax: 04721 / 718 - 200
E-mail: info@pnegroup.com
Internet: https://www.pnegroup.com
ISIN: DE000A0JBPG2, DE000A30VJW3
WKN: A0JBPG, A30VJW
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 2227666

 
End of News EQS News Service

2227666  11.11.2025 CET/CEST

Analysen zu PNE AG

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
18.08.25 PNE Buy Warburg Research
01.04.25 PNE Buy Warburg Research
24.02.25 PNE Buy Warburg Research
19.02.25 PNE Buy Warburg Research
04.12.24 PNE Buy Warburg Research
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest

Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.

Schnell noch Plätze sichern!

Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer

Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉

Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.

💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Abnehmspritzen – Ist der Hype vorbei? – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’193.40 19.16 SJ6B5U
Short 13’444.90 13.69 U2TBSU
Short 13’930.53 8.90 SY9BNU
SMI-Kurs: 12’702.08 11.11.2025 17:30:12
Long 12’163.68 19.77 SO2B2U
Long 11’889.18 13.84 SZDBEU
Long 11’379.10 8.90 SPMBUU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Aktien in diesem Artikel

PNE AG 9.58 4.76% PNE AG